Pharmaceutical & Healthcare Research Report

Breaking

Tuesday, April 23, 2019

Pontine Glioma Therapeutics- Pipeline Analysis 2018

Pontine glioma is a malignant tumour which develops from the brain stem cells. Based on the grade of growth, it is categorized into anaplastic astrocytomas and glioblastoma multiforme (GBM).


















Pontine glioma is more prevalent in children than adults. The common signs and symptoms of pontine glioma are squints, swallowing problems, slurred speech, facial weakness, abnormal gait, difficulty in writing and changes in personality and behaviour.

Request to get the sample report at: https://www.pharmaproff.com/request-sample/1117

The only efficient treatment for pontine glioma is radiotherapy; as surgery is not possible due to the tumor’s position in the brain stem. Company like Y-mAbs Therapeutics Inc. is in the process of developing omburtamab for the treatment of pontine glioma.

No comments:

Post a Comment